
We spoke with Dr. Gerald Falchook about the first human study of a first-in-class molecule, fatty acid synthase inhibitor known as TVB-2640 for advanced solid tumors.

Your AI-Trained Oncology Knowledge Connection!


Published: April 7th 2017 | Updated: